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Abstract 
Review on i(18)(q10) in haematological 
malignancies, with data on the genes involved. 
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Identity 
Isochromosome 18q is an unbalanced structural 
abnormality in which the short arm is lost and the 
remaining long arm is duplicated resulting in a 
chromosome consisting of two identical long arms. 
i(18)(q10) is a rare chromosome aberration found in 
a large spectrum of hematological malignances (61 
cases), most frequently in older patients (average age 
58.3 years) with complex karyotypes. The anomaly 
was described predominantly in lymphoproliferative 
disorders (54 cases), but a small number of cases 
with myeloid malignances and i(18q) were also 
reported. Isochromosome 18q resulted in a decrease 
and increase in gene dosage from the monosomy of 
the 18p arm and trisomy of the 18q arm, respectively. 
Clinics and pathology 
Disease Diffuse large B-cell 
lymphoma (DLBCL) 
Epidemiology 
i(18)(q10) is found in 1.5% of DLBCL cases with an 
abnormal karyotype.  Microarray DNA comparative 
genome hybridization studies have demonstrated 
that the incidence of 18q11.2-23 gains are 54% in the 
activated B-cell-like DLBCL and suggested that 
i(18q) is possibly much more frequent in this subtype 
of DLBCL (Nedomova et al.,2013).  
In BCL2 expressing germinal center B-cell-like 
DLBCL, the 18q11.2-23 gains were found more 
frequently in Chinese than in Western cases (Chen et 
al.,2010). Sex ratio of the cases with i(18q) is 
significantly unbalanced, near M:F=1.8:1 and the 
anomaly was observed mostly in older patient 
(average age 59.6 years; range 17-84). 
Cytogenetics 
Isochromosome 18q is presented in two types - 
single copy of i(18q) (41% of the cases) and 
supernumerary type i(18q) (59% of the cases) which 
included two or three copies of i(18q). 
Supernumerary type is frequently associated with 
+18 and the final number of the long arms of 
chromosome 18 in these cases reached 6 or 7 copies. 
All cases in the group of DLBCL are with complex 
karyotypes.  In 12 cases (55%) i(18q) is associated 
with del(6q) and in 6 cases (27%) with +3. 
Rearrangements in band 3q27 were seen in one case 
and t(8;14)(q24;q32) in three cases, respectively. 
There is no case with t(14;18)(q32;q21). 
The deregulation of BCL2 expression is highly 
associated with t(14;18)(q32;q21) in follicular 
lymphoma and germinal center B-cell-like DLBCL. 
The elevated expression of BCL2 due to a gain of 
18q is accepted as an alternative mechanism of gene 
upregulation observed mainly in the cases with ABC 
DLBCL 
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Figure 1 i(18)(q10;q10)  - partial G-banding karyotypes of the homologues 18; Fluorescence in situ hybridization with BCL2 
(18q21) break probe (Kreatech Diagnostic; Leica) showing three normal fusion signals for BCL2 - one in the long arm of the 
normal homolog 18 (red arrow) and one in each arm of the abnormal homolog 18 (green arrow); (patient with polycythemia vera, 
unpublished case - Lubomir Mitev, Lilya Grachlyova, Aselina Asenova). 
 
NFATC1 is a member of NATF (nuclear factor of 
activated T cell) family of transcriptional factors that 
regulates genes involved in the cell cycle, apoptosis 
and angiogenesis.  NFATC1 is frequently 
overexpressed in the cases of ABC DLBCL. 
Prognosis 
Prognosis of patients with i(18)(q10) is poor and this 
seems to be related to the additional copies of BCL2 
oncogene (located in 18q21) leading to 
overproduction of BCL2 protein (Lu et al.,2015). 
Disease Adult-T cell leukemia (ATL) 
Epidemiology 
i(18)(q10) is found in 3.5%  of ATL  cases with an 
abnormal karyotype.  The sex ratio is M:F=1.3:1. 
The anomaly was described only in older patients 
(average age 65.1 years; range 52-85). 
Cytogenetics 
In 7 cases i(18q) is found in complex karyotypes. In 
one case it was a second event appearing after clonal 
evolution of the disease, and in one it was a sole 
anomaly. In all cases except one i(18q) is presented 
with one copy in the karyotype. The case with 
supernumerary i(18)(q10) is associated with +18 and 
the final number of the copies of i(18q) in this case 
is 9. In 5 cases (56%) i(18q) is associated with sex 
chromosome abnormalities (one with structural 
aberration, two with -X and two with -Y). 
Genes 
A candidate gene possibly linked to the pathogenesis 
of the cases with ATL and i(18q) is PTPN2 (mapped 
on 18p11.21).  
The protein encoded by PTPN2 (Tyrosin-protein 
phosphatase non-receptor type2) is a member of the 
protein tyrosine phosphatase family that functions as 
a negative regulator of multiple signaling pathways 
including IL2 (interleukin 2) mediated JAK/STAT 
cascade. PTPN2 is inactivated by nonsense mutation 
in 5% and deleted in 6% of the cases with adult acute 
T-cell lymphoblastic leukemia (Kleppe et al.,2010; 
Kleppe ae al.,2011). At the same time deregulation 
of JAK/STAT pathway is a frequent event in ATL 
(Takemoto et al.,1997) and one of the reason for this 
could be 18p deletion, respectively loss of PTPN2 as 
a result of i(18q). 
Prognosis 
It is not clear if there is a difference of the prognosis 
between the cases with ATL carrying i(18q) and the 
cases without the anomaly because of the small 
number of the reported cases with i(18q). 
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Disease Follicular lymphoma (FL) 
Epidemiology 
i(18)(q10) is found in 0.3%  of FL  cases with an 
abnormal karyotype.  The anomaly is described 
predominantly in males (4 males and one female). 
Cytogenetics 
All reported cases are with complex karyotypes. 
Two cases are with single copy of i(18)(q10) and 
three cases are with supernumerary i(18)(q10) (2 or 
3 copies). In two cases i(18q) is associated with 
t(14;18)(q32;q21) and in one with monosomy of 
chromosome 18. 
Genes 
The overexpression of BCL2 as a result of an 
increased number of copies of i(18q) or a 
combination of i(18q) and t(14;18)(q32;q21) is 
linked to the pathogenesis of FL. 
Prognosis 
Prognosis is unclear because of the very small 
number of cases. 
Disease Mature B-cell neoplasms, 
NOS (MBN) 
Epidemiology 
i(18)(q10) is found in 0.8%  of MBN  cases with an 
abnormal karyotype, predominantly in males (5 
males and one female), and was observed only in 
older patients (average age 59.5 years; range 41-77). 
Cytogenetics 
All reported cases are with complex karyotypes and 
i(18)(q10) is presented only with one copy in the 
karyotype. In one case the anomaly is accompanied 
with t(14;18)(q32;q21) and in one with 
t(8;14)(q24;q32). 
Genes 
The additional copy of BCL2 may be related to the 
pathogenesis of the disease. 
Prognosis 
Prognosis is unclear because of the very small 
number of cases. 
Disease Other lymphoproliferative 
disorders 
Epidemiology 
i(18q) is found in 3 cases (0.2% of all cases with an 
abnormal karyotype) with multiple myeloma (MM),  
2 cases with mature T-and NK cell neoplasms 
(NOS), 2 cases (3.3% of all cases with an abnormal 
karyotype) with Hodgkin disease, 2 cases with 
extranodal marginal zone B- cell lymphoma 
(MALT) of salivary gland, 2 cases with acute 
lymphoblastic leukemia/ lymphoma and 1 case with 
mantle cell lymphoma (MCL). 
Cytogenetics 
In all cases of this heterogeneous group of diseases 
except one (with isolated i(18q) in case of MALT 
lymphoma), i(18q) is found in complex karyotypes 
as a single copy. In one case of hypotetraploid type 
of MM i(18q) is associated with a 14q32 
rearrangement and the case with MCL with 
t(11;14)(q13;q32). 
Disease Myeloproliferative diseases 
(MPD 
Epidemiology 
i(18q) was found  in 6 cases (0.07% of all cases with 
an abnormal karyotype) with acute myeloid 
leukemia (AML) -  2 with M2 French-American-
British (FAB) phenotype and 4 with AML, NOS. In 
one case i(18q) was observed in polycythemia vera 
(unpublished case). The AML patients are 
predominantly males (5 males and one female) and 
are with an average of 50.3 years (range 11- 78). 
Cytogenetics 
In all AML cases i(18q) is presented  as a single copy 
in a complex karyotypes and is associated with 
numerical or structural abnormalities of 
chromosome 5 or 8. The i(18q) was found in the case 
of PV as an isolated anomaly and was associated 
with mutation of JAK2 gene. 
Genes 
The molecular pathogenesis of i(18q) in the cases 
with AML is unknown.  This anomaly may be 
accepted as a variant of the unbalanced 
der(9;18)(p10;q10) found in JAK2 positive cases 
with PV and AML following post polycythemic 
myelofibrosis (Bacher and Haferlach,2006). It is 
known that the downregulation of PTPN2 expression 
(located in 18p11.21) is due to increased activation 
of JAK/STAT pathway particularly in the cases with 
JAK2 mutation. That is why it is logical to suppose 
that PTPN2 deletions as a result of i(18q) are 
responsible for the progression of the JAK2 positive 
chronic MPD. 
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